Israeli study finds Pfizer COVID-19 booster protects against Omicron

Israeli study finds Pfizer COVID-19 booster protects against Omicron
# 12 December 2021 08:41 (UTC +04:00)

Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech (PFE.N), (22UAy.DE) COVID-19 vaccine provided significant protection against the new Omicron variant, APA reports quoting Reuters.

The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.

The study, carried out by Sheba Medical Center and the Health Ministry's Central Virology Laboratory, compared the blood of 20 people who had received two vaccine doses 5-6 months earlier to the same number of individuals who had received a booster a month before.

"People who received the second dose 5 or 6 months ago do not have any neutralization ability against the Omicron. While they do have some against the Delta (strain)," Gili Regev-Yochay, director of the Infectious Diseases Unit at Sheba, told reporters.

#
#

THE OPERATION IS BEING PERFORMED